+ There were differences in outcome of early response, CR after induction treatment, OS and EFS among risk groups according to genetic variation of B-ALL: High risk groups had the lowest OS and EFS. Patients who had fusion gene BCR-ABL1 had lower OS and EFS than other patients in the same group of FRALLE 2000 regimen.